海泰新光跌1.01%，成交额1.17亿元，今日主力净流入-772.68万

Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is experiencing a decline in stock price but benefits from its strong position in the medical device sector and the depreciation of the RMB, which enhances its overseas revenue. Group 1: Company Overview - The company focuses on integrating optical technology with cutting-edge applications in the medical device industry, particularly in high-performance endoscopic instruments [2] - As of September 30, the company reported a revenue of 448 million yuan, a year-on-year increase of 40.47%, and a net profit of 136 million yuan, also reflecting a 40.03% growth [7] - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and technological capabilities [3] Group 2: Financial Performance - The company's overseas revenue accounts for 69.12% of total revenue, benefiting from the depreciation of the RMB [3] - The average trading cost of the stock is 46.52 yuan, with the current price near a support level of 46.80 yuan, indicating potential for a rebound if this level holds [6] - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [8] Group 3: Market Activity - The stock experienced a decline of 1.01% on February 2, with a trading volume of 117 million yuan and a turnover rate of 2.04%, resulting in a total market capitalization of 5.622 billion yuan [1] - There has been a net outflow of 7.7268 million yuan from major investors, indicating a reduction in holdings over the past two days [4][5]